免疫チェックポイント阻害による併用がん治療:インターフェロン信号の収束

Andy J Minn¹, E John Wherry²

¹Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Cell

|April 9, 2016

まとめ

免疫チェックポイント阻害療法と他の治療法を組み合わせることで,がん治療の有効性が向上します. インターフェロンと先天的な免疫信号伝達経路は,治療反応と耐性を複雑に影響する.

科学分野:

免疫学
腫瘍学
ガン治療

背景:

免疫チェックポイントブロック (ICB) は現代の癌治療の基石です
ICBの有効性の向上は,治療抵抗性の克服に不可欠です.
インターフェロンと先天的な免疫信号伝達経路は,ICB応答において複雑な役割を果たします.

研究の目的:

免疫チェックポイントブロックの有効性を改善する戦略を探求する.
インターフェロンと先天的な免疫シグナル伝達がICB応答と抵抗における役割を調査する.

主な方法:

他の薬剤とのICBを含む組み合わせ治療法.
免疫細胞と腫瘍細胞におけるインターフェロンと先天的な免疫信号伝達経路の分析

主要な成果:

ICB剤を互いに組み合わせたり,他の治療法と組み合わせたりすると,有効性が向上します.
インターフェロンと先天的な免疫信号伝達経路は,応答と抵抗の重要な決定因子です.
これらの経路は治療結果に複雑で時には矛盾する影響を及ぼします

結論:

組み合わせ治療は,ICBの有効性を高める有望な戦略です.
インターフェロンと先天的な免疫の複雑な役割を理解することは癌治療の最適化に不可欠です

さらに関連する動画

09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.9K

06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.7K

関連する概念動画

01:27

Tumor Immunotherapy

2.1K

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

2.1K

02:50

Combination Therapies and Personalized Medicine

6.3K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

6.3K

02:50

Combination Therapies and Personalized Medicine

1.8K

02:57

Targeted Cancer Therapies

9.1K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

9.1K

02:57

Targeted Cancer Therapies

1.7K

01:19

Interactions Between Signaling Pathways

7.8K

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...